HUMAN PAPILLOMA VIRUS

Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.

Never miss a new study

Get alerted when new HUMAN PAPILLOMA VIRUS trials appear

Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 4 Not yet finished but already full! 10 Completed 10 Terminated 1

ERs could be key to boosting HPV shots in High-Risk adults

Prevention Terminated

This study explored whether giving the HPV vaccine in the emergency department (ER) could help protect adults aged 18-45 who haven't been fully vaccinated. Researchers enrolled 34 participants and offered the vaccine during their ER visit, with follow-up doses at 2 and 6 months. …

Matched conditions: HUMAN PAPILLOMA VIRUS

Sponsor: University of Alabama at Birmingham • Aim: Prevention

Last updated Jun 27, 2026 12:09 UTC

HUMAN PAPILLOMA VIRUS

Get alerted when new HUMAN PAPILLOMA VIRUS trials appear

ERs could be key to boosting HPV shots in High-Risk adults